Introduction:

Stratification of risk for major complications (including mortality) is the current fundamental clinical strategy for making therapeutic decisions in patients with pulmonary arterial hypertension. However, it is noticeable that most of patients are grouped in the intermediate category both at the time of diagnosis and during follow-up. Highlighting the relevance and necessity to improve discrimination and therapeutic options for patients at intermediate risk.

Objective:

To define a series of recommendations on the proper subclassification, follow-up, and treatment of adult patients with pulmonary arterial hypertension at intermediate risk, adapted to the Colombian context.

Method:

15 experts in pulmonary hypertension were invited. They voted according to the modified Delphi methodology around 14 questions, on which a systematic review of the literature was carried out in several bibliographic bases: VHL, Cochrane Library, PubMed, Medline and Web of Science. The MeSh and DeCs criteria for each question were used without language or time limits.

Results and discussion:

The present study provides a series of 18 consensus recommendations on stratification, treatment and other sections. Additionally, the initiative makes it possible to identify the insufficiency of scientific studies in our country that determine the behavior of the disease, access barriers and availability of medicines in our country.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )